What’s the Question?
More than 55 million adults in the United States use cannabis or other drugs, and approximately 7% meet DSM-5 diagnostic criteria for substance use disorder (SUD). However, the number of patients that receive such a diagnosis is much lower (0.8-4.6…
What's the Question?
American Indian and Alaska Native (AI/AN) communities are disproportionately impacted by the opioid overdose epidemic. Though past-year rates of opioid misuse are similar between AI/AN communities and non-Hispanic whites, the proportion of overdose…
What’s the Question?
Learning collaboratives are increasingly used in behavioral health to improve the quality and effectiveness of care. They generally involve bringing together teams from different organizations and using experts to educate and coach those teams in…
What’s the Question?
Rising rates of deaths from opioid overdoses in the U.S. underscore the importance of expanding access to medications to treat opioid use disorder (MOUD), like methadone, buprenorphine, and naloxone.
Barriers to accessing methadone, however,…
What’s the Question?
Respect for diverse identities, including race, ethnicity, gender identity, sexual orientation, cultural and religious background, and age, is extremely important in a medical setting. Patients and families are frequently cited as the individuals…
What’s the Question?
Research has shown that treatment with medication for opioid use disorder (MOUD), like methadone, buprenorphine, or extended-release injectable naltrexone, can decrease both risk for overdose and death from other causes for people with opioid use…
What’s the Question?
Co-use of opioids and stimulants, especially methamphetamine and cocaine, has been increasing and contributes to our growing overdose epidemic. Medications for opioid use disorder (MOUD), like buprenorphine and extended-release naltrexone (XR-NTX),…
What’s the Question?
While the search for medications to address stimulant use disorder remains elusive, contingency management (CM) is a behavior therapy for which there is strong evidence of effectiveness in improving treatment adherence among persons with stimulant…
What’s the Question?
The use of both cannabis and nicotine/tobacco products is common in the U.S. and is associated with greater prevalence of mental health issues. Though several studies have found that people who use both cannabis and nicotine use more…
What’s the Question?
Addiction treatment providers offer counseling, medical care, and community supports for those struggling with substance use disorders (SUDs) and are often tasked with providing support for associated behavioral health conditions, like…